EUVIMEDOpdag EUVIMED
EUVIMED · CrossrefJournal

Anticancer Research

ISSN 0250-7005 · International Institute of Anticancer Research

Latest articles

  1. Efficacy of Lenvatinib as Subsequent Therapy After Combination Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma

    NAOKI UCHIHARA, NOBUHARU TAMAKI, HIROYUKI MARUSAWA, NAOHITO URAWA, CHITOMI HASEBE, HIROTAKA ARAI, HIRONORI OCHI, MASAHIKO KONDO, NAMI MORI, KEIJI TSUJI, HIDEKI FUJII, CHIKARA OGAWA, YASUSHI UCHIDA, HIROMITSU MORI, JUNICHI TOSHIMORI, EISUKE OKAMOTO, MASAYA SHIGENO, TAKEHIRO AKAHANE, RYOICHI NARITA, HIDEO YOSHIDA, KEISUKE YOKOHAMA, YOSHIHITO KUBOTSU, YOICHI YASUDA, TOSHIFUMI TADA, SHINICHIRO NAKAMURA, KAORU TSUCHIYA, YUTAKA YASUI, NAMIKI IZUMI, MASAYUKI KUROSAKI

    Published: 2026-08DOI: 10.21873/anticanres.18300

  2. Effectiveness and Safety of Enfortumab Vedotin Plus Pembrolizumab for Patients Aged 80 Years and Older With Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study

    YUKI KOBARI, NAO NAKAJIMA, AKIRA SAITO, NANAKA KATSURAYAMA, TORU INAKAWA, SATOSHI KUBOTA, YUKI NEMOTO, KAZUTAKA NAKAMURA, KOUICHI NISHIMURA, HIROKI ISHIHARA, TAKAFUMI YAGISAWA, HIRONORI FUKUDA, KAZUHIKO YOSHIDA, JUNPEI IIZUKA, HIROAKI SHIMMURA, YASUNOBU HASHIMOTO, TSUNENORI KONDO, HIROSHI KOBAYASHI, TOSHIO TAKAGI

    Published: 2026-08DOI: 10.21873/anticanres.18301

Volumes

2026 · 5562025 · 5312024 · 6052023 · 6542022 · 6762021 · 7192020 · 8252019 · 8472018 · 8922017 · 8212016 · 3012009 · 1

Viden, der passer til dit arbejde.

Fra en gratis start over personlig litteratursøgning til den komplette Research Suite.

Se priser →

Er alle forlagsfuldtekster inkluderet?

Nej. Bibliografiske referencer, abstracts og fuldtekster er forskellige typer indhold. Om en fuldtekst er tilgængelig, afhænger af kilden, Open Access og dine eksisterende licenser. Et EUVIMED-abonnement erstatter ikke yderligere forlagsrettigheder.